Navigation Links
Mayo Clinic study finds that after heart attack most patients stop taking life-saving drugs
Date:11/5/2007

ORLANDO, Fla. -- Recovery from heart attacks is best served by continuing to take prescribed medications. Yet more than half of patients who have had a heart attack stop taking these lifesaving medications within three years, according to results from a Mayo Clinic study presented today at the American Heart Associations Scientific Sessions 2007 in Orlando, Fla.

The Mayo data also show that in the short term, smokers are more likely to discontinue taking all of their prescribed heart medications, whereas in the long term, data show that patients enrolled in cardiac rehabilitation programs tend to continue their medications at a higher rate than patients who do not enroll. The researchers suggest their data support a two-pronged strategy for improving the publics heart health: 1) target heart patients who smoke for education on complying with physicians aftercare advice about continuing medications, and 2) encourage all heart patients to participate in a cardiac rehabilitation program, possibly increasing their likelihood of continuing prescribed treatments.

Significance of the Mayo Clinic Research

The study was designed to improve recovery and quality of life after heart attack by determining how well patients comply with physicians recommendations. It clearly documented that treatments exist that improve outcomes following heart attacks -- but patients need to comply with the treatment regimens for the goal of improved patient health to be realized, says Nilay Shah, Ph.D., the studys lead researcher.

By following patients at six, 12 and 36 months after a heart attack, the researchers discovered that smokers are most likely to stop taking their medication, placing them at increased risk for more heart attacks and complications, says Dr. Shah. This suggests that current smokers may be a target group for education acute heart attack. Participation in cardiac rehab programs seems to be another important factor associated with long-term continuation of prescribed medication therapy, he says.

Patients discontinue taking medications too soon for a variety of reasons, including cost, says Veronique Roger, M.D., M.P.H., co-author of the study. More research is crucial to understand and resolve the barriers patients face as they recover from heart attacks she says.

About the Study

In their study, the Mayo researchers evaluated 292 patients, a subset of all the patients who were enrolled in the Olmsted County, Minn., registry of acute heart attacks. This subset also had prescription drug claims data available from another source. The team looked at long-term data (up to 10 years) for patients who had heart attacks and who were discharged from the hospital and taking ACE inhibitors, beta-blockers and statins to help prevent another heart attack.

Results showed that:

  • At six months, smokers were significantly less likely to continue all three heart medications compared to nonsmokers.

  • At six months, 92 percent of the patients taking statins continued treatment, and by three years only 44 percent of the patients continued taking statins.

  • Similarly, the rate of beta-blocker continuation dropped from 89 percent at six months to 47 percent at three years.

  • The rate of ACE inhibitor continuation dropped from 77 percent at six months to 37 percent at three years.


'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: